Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD

Thorax

Volumn 68, Issue 9, 2013, Pages 803-811

  Ricciardolo, Fabio L M ^a   Sabatini, Federica ^b   Sorbello, Valentina ^a   Benedetto, Sabrina ^a   Defilippi, Ilaria ^a   Petecchia, Loredana ^c   Usai, Cesare ^c   Gnemmi, Isabella ^d   Balbi, Bruno ^d   De Rose, Virginia ^a   Ten Hacken, Nick H T ^e   Postma, Dirkje S ^e   Timens, Wim ^e   Di Stefano, Antonino ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c CNR   (Italy)

^d IRCCS   (Italy)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; BIOLOGICAL MARKER; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; CD31 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; VASCULOTROPIN A;

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; BLOOD VESSEL FUNCTION; BRONCHIAL VASCULAR REMODELLING; BRONCHUS; BRONCHUS BIOPSY; CELL COUNT; CELLULAR DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAMINA PROPRIA; LUNG CAPILLARY; LUNG ENDOTHELIUM; LUNG FIBROBLAST; MALE; MAST CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SMOKING;

ASTHMA MECHANISMS; COPD PATHOLOGY;

ADAPTATION, PHYSIOLOGICAL; ADULT; AGE FACTORS; AGED; ANTIGENS, CD31; ASTHMA; BIOLOGICAL MARKERS; BRONCHI; CAPILLARIES; CASE-CONTROL STUDIES; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RIBONUCLEASE, PANCREATIC; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84881548755     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202741     Document Type: Article

References (35)

1. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:S28-38.
2. Postma DS, Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:434-9. (Pubitemid 44033359)
3. Hashimoto M, Tanaka H, Abe S. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 2005;127:965-72. (Pubitemid 40775530)
4. Asosingh K, Erzurum SC. Angioplasticity in asthma. Biochem Soc Trans 2009;37:805-10.
5. Thebaud B, Ladha F, Michelakis ED, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005;112:2477-86. (Pubitemid 41504498)
6. Presta M, Andres G, Leali D, et al. Inflammatory cells and chemokine sustain FGF2-induced angiogenesis. Eur Cytokine Netw 2009;20:39-50.
7. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301. (Pubitemid 32173907)
8. Feltis BN, Wignarajah D, Zheng L, et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med 2006;173:1201-7. (Pubitemid 43848389)
9. Asai K, Kanazawa H, Kamoi H, et al. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 2003;33:595-9. (Pubitemid 36629683)
10. Hofstaetter JG, Saad FA, Sunk IG, et al. Age-dependent expression of VEGF isoforms and receptors in the rabbit anterior cruciate ligament. Biochim Biophys Acta 2007;1770:997-1002. (Pubitemid 46678608)
11. Adams SA, Subramanian V. The angiogenins: an emerging family of ribonuclease related proteins with diverse cellular functions. Angiogenesis 1999;3:189-99. (Pubitemid 129644147)
12. Kishimoto K, Liu S, Tsuji T, et al. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005;24:445-56. (Pubitemid 40188592)
13. Simcock DE, Kanabar V, Clarke GW, et al. Proangiogenic activity in bronchoalveolar lavage fluid from patients with asthma. Am J Respir Crit Care Med 2007;176:146-53. (Pubitemid 47057850)
14. Abraham WM, Scuri M, Farmer SG. Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease. Eur J Pharmacol 2006;533:215-21. (Pubitemid 43340014)
15. Ricciardolo FL, Vergnani L, Wiegand S, et al. Detection of nitric oxide release induced by bradykinin in guinea pig trachea and main bronchi using a porphyrinic microsensor. Am J Respir Cell Mol Biol 2000;22:97-104. (Pubitemid 30342965)
16. Figini M, Ricciardolo FL, Javdan P, et al. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide. Am J Respir Crit Care Med 1996;153:918-23.
17. Knox AJ, Corbett L, Stocks J, et al. Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB 2001;15:2480-8. (Pubitemid 33063176)
18. Koyama S, Sato E, Tsukadaira A, et al. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J 2002;20:1449-56. (Pubitemid 35460614)
19. Ricciardolo FL, Nadel JA, Bertrand C, et al. Tachykinins and kinins in antigen-evoked plasma extravasation in guinea-pig nasal mucosa. Eur J Pharmacol 1994;261:127-32. (Pubitemid 24263212)
20. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). NHLBI/WHO workshop report. Bethesda, National Heart, Lung and Blood Institute. http://www.ginasthma.org/Updated 2007.
21. Wenzel SE, Fahy JV, Irvin CG, et al. Proceedings of the ATS Workshop on Refractory Asthma: current understanding, recommendations and unanswered questions. Am J Respir Crit Care Med 2000;162:2341-51. (Pubitemid 32051710)
22. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. ethesda, National Heart, Lung and Blood Institute. http://www.goldcopd.org/Updated 2010.
23. Hayashi R, Yamashita N, Matsui S, et al. Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur Respir J 2000;16:452-8.
24. Wheeler-Jones CP, Farrar C, Garonna E. Protease-activated receptors, cyclo-oxygenases and pro-angiogenic signalling in endothelial cells. Biochem Soc Trans 2009;37:1179-83.
25. Zanini A, Chetta A, Imperatori AS, et al. The role of the bronchial microvasculature in the airway remodeling in asthma and COPD. Resp Res 2010;11:1-11.
26. Kristan SS, Marc MM, Kern I, et al. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease. Scand J Immunol 2011;75:109-14.
27. Demedts IK, Demoor T, Bracke KR, et al. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res 2006;7:53.
28. Mak JCW, Barnes PJ. Autoradiographic visualization of bradykinin receptors in human and guinea pig lung. Eur J Pharmacol 1991;194:37-43.
29. Colman RW. Regulation of angiogenesis by the kallikrein-kinin system. Curr Pharm Des 2006;12:2599-607.
30. Petecchia L, Sabatini F, Usai C, et al. Mechanisms of bradykinin-induced contraction in human fetal lung fibroblast. Eur Respir J 2010;36:1-10.
31. El Karim IA, Linden GJ, Irwin CR, et al. Neuropeptides regulate expression of angiogenic growth factors in human dental pulp fibroblasts. J Endod 2009;35:829-33.
32. Chung KF, Rogers DF, Barnes PJ, et al. The role of increased airway microvascular permeability and plasma exudation in asthma. Eur Respir J 1990;3:329-37. (Pubitemid 20128555)
33. Ricciardolo FLM, Geppetti P, Mistretta A, et al. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 1996;348:374-7. (Pubitemid 26261512)
34. Bork K, Frank J, Grundt B, et al. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol 2007;119:1497-503. (Pubitemid 46855846)
35. Akbarg AM, Wirth KJ, Schoelkens BA. Efficacy and tolerability of Icatibant (HOE 140) in patients with moderately severe chronic bronchial asthma. Immunopharmacology 1996;33:238-42. (Pubitemid 26247939)